 Ortho Regenerative Technologies Inc CSE:ORTH announced that it has changed its corporate name to ChitogenX Inc to better reflect the companys expanded clinical and commercial opportunities, mission, values, and core competencies. The companys shares are expected to begin trading on the Canadian Stock Exchange under the new name and new ticker symbol, CHGX at market open on or around September 12, 2022, the clinical-stage orthobiologics company focused on the development of novel soft tissue repair regenerative technologies noted. 